BOHE Angel Fund
VC Fund
Suzhou, China
BOHE Angel Fund is an investment Fund.
- Total investments:
- 16
- Last investment:
- Lead investor:
- 19%
Last updated:
For AI agents: llms.txt
Industries BOHE Angel Fund invests in
Stages BOHE Angel Fund invests in
Countries BOHE Angel Fund invests in
Round sizes
Round size
- Seed
- $14M–$15M
- Angel
- $1.4M–$100M
Investment Focus
Industry
- Health Care 9 (56%)
- Medical 6 (38%)
- Biotechnology 5 (31%)
- Life Science 2 (13%)
- Pharmaceutical 2 (13%)
Stage
- Angel 6 (38%)
- Seed 4 (25%)
- Series A 3 (19%)
- Series B 1 (6%)
- Venture - Series Unknown 1 (6%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
PrinoPharma
|
PrinoPharma focuses on developing novel druggable sites targeting difficult-to-drug or existing druggable targets. | $14.5M / Angel / Mar 10, 2026 | |
| Qinhao Pharmaceutical is harmaceutical enterprises with a gathering of humanities and innovation. | $43M / Venture - Series Unknown / Jan 13, 2026 | ||
| KangaBio is a biotech business specializing in developing novel medicines to meet unmet medical needs. It helps in developing prodrugs of immune-stimulating medicines and other multi-specific biologics to minimize toxicities and boost treatment efficacy for already established targets. | $15M / Seed / Dec 01, 2025 | ||
Yili Pharmaceutical
|
Yili Pharmaceutical is a pharmaceutical R&D company that mainly engages in biochemical product technology R&D, medical research and experimental development, engineering and technology research and experimental development, and software development. | $14M / Angel / Sep 25, 2025 | |
|
Yuanke Medical
|
Yuanke Medical is a company focused on medical device operations and technical services. Its core activities include R&D, sales, and support for medical devices, providing high-quality solutions to healthcare institutions. | Seed / Aug 19, 2025 | |
|
Yili Pharmaceutical
|
Yili Pharmaceutical is a pharmaceutical R&D company that mainly engages in biochemical product technology R&D, medical research and experimental development, engineering and technology research and experimental development, and software development. | $100M / Angel / Dec 24, 2024 | |
|
Yili Pharmaceutical
|
Yili Pharmaceutical is a pharmaceutical R&D company that mainly engages in biochemical product technology R&D, medical research and experimental development, engineering and technology research and experimental development, and software development. | $13.7M / Seed / Dec 24, 2024 | |
| QuarkMed is a nuclear medicine clinical CRO service company. | Series A / Oct 11, 2024 | ||
| Tyligand Bioscience is a biotechnology company that focuses on the discovery and development of small molecule therapeutics to help patients with cancer and autoimmune diseases. Tyligand's pharmaceuticals are designed to target and treat tumors and autoimmune disorders, enabling healthcare professionals to prescribe more effective medicine andimprove health outcomes. | Series A / Jul 08, 2023 | ||
| Levostar is a biotechnology company that specializes in the development and manufacture of cell and gene therapy products. | Seed / Apr 11, 2022 | ||
| See all 16 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does BOHE Angel Fund invest in?
BOHE Angel Fund invests primarily in Health Care, Medical and Biotechnology startups, most often at Angel and Seed stage. Most of the 16 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does BOHE Angel Fund invest in?
BOHE Angel Fund typically joins rounds of $14M–$15M at Seed and $1.4M–$100M at Angel. These are whole funding-round sizes, not BOHE Angel Fund's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds BOHE Angel Fund took part in.
When did BOHE Angel Fund last invest?
The most recent investment recorded for BOHE Angel Fund closed in Mar 2026. Shizune tracks 16 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
